From: Identification of lung cancer with high sensitivity and specificity by blood testing
NSCLC | SCLC | |
---|---|---|
Total number, n (%) | 29 (61.7) | 18 (38.3) |
- adenocarcinoma, n (%) | 11 (37.9) | |
- large cell carcinoma, (%) | 9 (31.0) | |
- squamous cell carcinoma, n (%) | 9 (31.0) | |
age mean, years (range) | 64.00 (45-83) | 60.44 (49-74) |
male, n (%) | 16 (55.2) | 9 (50) |
female, n (%) | 13 (44.8) | 9 (50) |
Clinical staging, n (%) | ||
I | 21 (72.4) | 1 (5.6) |
II | 2 (6.9) | 0 (0) |
III | 5 (17.2) | 13 (72.2) |
IV | 0 (0) | 2 (11.1) |
unknown | 1 (3.4) | 2 (11.1) |